News | Digital Radiography (DR) | April 24, 2019

Samsung Demonstrates Viability of Lower Dose Digital Radiography Algorithm for Pediatric Patients

S-Vue 3.02 image post-processing engine offers greater diagnostic confidence with up to 45 percent dose reduction to improve pediatric patient care

Samsung Demonstrates Viability of Lower Dose Digital Radiography Algorithm for Pediatric Patients

April 24, 2019 — Samsung announced that its new image post-processing engine (IPE), S-Vue 3.02, recently received U.S. Food and Drug Administration (FDA) clearance. The technology employs an advanced noise-reduction algorithm that allows devices to produce the same high-quality image using a fraction of the radiation in pediatric patients. Image evaluations on devices using S-Vue showed they reduced X-ray dose up to 45 percent for pediatric abdomen exams,* 15.5 percent for pediatric chest exams, and up to 27 percent for pediatric skull exams as compared with the previous IPE on the same X-ray systems.

Samsung’s digital radiography (DR) machines – including GC85A and GM85 – incorporate S-Vue 3.02, which provides spatially adaptive multi-scale processing and advanced de-noising technology, delivering quality images with a fraction of the dose.

“Findings of our clinical trial showed that use of Samsung’s S-Vue for pediatric chest images resulted in an overall image quality that was uncompromised even at a significantly reduced radiation exposure,” said Susan John, M.D., professor and chair, diagnostic and interventional imaging at McGovern Medical School at The University of Texas Health Science Center at Houston (UT Health). “The reduction in radiation dose potentially enables repeat radiographs for better follow-up in patients from infancy into adulthood, while assisting us in confident diagnosis.”

For more information: www.samsunghealthcare.com

*The claim concerning Samsung DR is based on limited phantom and clinical study results. Only routine PA chest radiography and abdominal radiography for average adults and pediatric abdominal, chest, skull radiography were studied, excluding pediatric patients under 1 month old.

Related Content

Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Feature | Digital Radiography (DR) | July 19, 2019 | By Greg Freiherr
Recent advances in...
Low Doses of Radiation Promote Cancer-capable Cells
News | Radiation Dose Management | July 18, 2019
Low doses of radiation equivalent to three computed tomography (CT) scans, which are considered safe, give cancer-...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
Image by rawpixel from Pixabay

Image by rawpixel from Pixabay 

Feature | Radiology Business | July 18, 2019 | By Stefanie Manack and Judy Zakutny
Approximately 30 percent of a hospital or health system’s profit comes from imaging according, to...
Mirion Showcases Instadose2 Wireless Dual Detector Dosimeter at AAPM and AHRA
News | Radiation Dose Management | July 15, 2019
Featuring dual detectors, the Instadose2 dosimeter addresses international requirements for independent deep [Hp(10)]...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity.

Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity. UW-Madison was the first site in the U.S. to get this technology. Its use is now being integrated into UW CT protocols. Image courtesy of Timothy P. Szczykutowicz

Feature | Computed Tomography (CT) | July 12, 2019 | By Greg Freiherr
When providers develop their own imaging protocols, they are wasting time and money, according to...
Fluke Biomedical Introduces RaySafe 452 Survey Meter
Technology | Radiation Dose Management | July 11, 2019
Radiation measurement often requires different devices for varying applications, adding to the cost and complexity of...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...